This AMP certificate program contains 5.5 hours of lecture content, the associated pdf slides of the lectures, a post-course exam, and an AMP Certificate of Completion.

If you are interested in claiming CME/CMLE or SAM, see the table below to purchase the certificate program + CME/CMLE or the certificate program + SAM.

The ability to understand the world through the use of molecular tools has led to fascinating discoveries in the field of microbiology and infectious diseases. In this certificate program, participants will learn about the current state-of-the-art infectious disease topics with the emphasis on the key topics and advances in infectious disease testing and their impact on patient care practices and in public health. This certificate program will review updates on what's new in sexually transmitted disease (STD) care, rapid diagnostics point of care tests, metagenomics also known as microbiome and its impact of bacterial diversity (microbiome), and human health by using next- generation sequencing.

Click on the Topics Tab to see the talks that are included in the Certificate Program.

Target Audience: Clinical and research lab professionals at any level (clinical lab professional, researcher, educator, clinicians, graduate or undergraduate students)

This certificate program was planned and coordinated by the Content Directors:

  • Preeti Pancholi, PhD, Ohio State University Wexner Medical Center
  • Sophie S. Arbefeville, MD, University of Minnesota Medical Center

and supported by the Training & Education Committee

Duration: 5.5 hours

About AMP Certificate Programs: AMP Certificate Programs are thematically bundled packages containing some repurposed and some newly recorded content and does not necessarily build on previous recordings. It is designed to help you develop knowledge and skills needed for success in molecular pathology and diagnostics. Each program is reviewed, vetted, and curated by expert content directors. All certificate programs include a post-course final exam and an AMP Certificate of Completion. Some certificate programs are also available for CME/CMLE or SAMs credit. Click on the links on the table below to purchase AMP Certificate + CME/CMLE or AMP Certificate + SAM.

CME/CMLE or SAMs: If you wish to obtain CME/CMLE or SAMs, click on the appropriate link to purchase the collection +CME/CMLE or +SAM. These also contain the AMP Certificate of Completion

Credit Type

Number of Credit Hours Available

Click on link to purchase:


Up to 3.0

Purchase collection + CME/CMLE + AMP certificate


Up to 3.0

Purchase collection + SAM + AMP certificate

Continuing education credit must be purchase and claimed by March 20, 2020


* You may not submit SAMs and CME/CMLE credit for the same content.

You might also be interested in:


Note: Members of AMP can access this webinar for a discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.

Course Information
Course Date:
March 31, 2019
Introduction and Course Materials
Molecular Point-of-Care-Tests for Infectious Diseases: Opportunities and Challenges


Point-of-care-tests (POCTs) provide rapid actionable results at the time and site of patient encounter. Traditionally, lateral flow immunoassays have been used for this purpose. Recently, emerging molecular methods have been developed to meet the needs for speed, low cost, and ease of use of POCTs for a wide variety of infectious diseases.


Learning Objectives

-Describe current and emerging technologies for molecular infectious disease testing at the point of care.

-Explain the major drivers for development of these tests in resource limited and rich countries.

-Discuss the unique challenges associated with deployment of molecular tests in near patient settings.


Speaker: Frederick S. Nolte, PhD


Recorded: December 2018

infectious diseases
Nucleic Acid Amplification Techniques
Rapid Antigen Detection Tests
Group A Streptococcus
Diagnosis of Sexually Transmitted Infections


This webinar will provide an update to both providers and laboratory personnel on the changing epidemiology of the most common STIs in the US and address current guideline recommendations and recent literature for STI diagnosis and testing. In addition, newly FDA-cleared diagnostics for detection of STIs or genital infections and unique testing situations, such as self-collection or POCT.

Learning Objective:

-List at least two new updates and/or epidemiological trends as described from the most recent CDC guidelines on STI diagnosis and treatment.

-Describe at least two newly FDA-cleared test systems for genital infections.

-Discuss situations where unique testing options might be considered (self-collection, POCT)


Speaker: Kimberle C. Chapin, MD

Duration1 hr

Recorded: February 2019

infectious diseases
Sexually Transmitted Diseases
Sexually Transmitted Infections
C. trachomatis
N. gonorrhea
T. vaginalis
Metagenomics in the Clinical Lab


With continued automation in the clinical microbiology and virology laboratory, laboratory artisans are looking for the next assay to develop with clinical impact. Metagenomic next-generation sequencing has emerged as an intriguing technology for its ability to detect pathogen nucleic acid from a variety of clinical samples in an unbiased manner. That said, it also has a number of challenges, such as cost and turn-around time. This webinar will explore some of the applications for metagenomic next-generation sequencing going on in clinical laboratories around the world today.


Learning Objectives:

-Describe the types of next-generation sequencing as applied to metagenomics.  

-Use metagenomics for reference lab testing appropriately.  

-Describe the challenges to metagenomic test validation.

Speaker: Alex L. Greninger MD, PhD

Duration: 1.25 hr

Recorded: March 2019

infectious diseases
Cerebral Spinal Fluid
Bronco alveolar lavage
A Collaborative Effort to End the Pandemic Era: The Global Virome Project


The ability to understand the world through the use of molecular tools has led to fascinating discoveries. The Global Virome project is a ten-year project to pre-empt emerging pandemic threats by identifying the majority of unknown viruses throughout the world that are likely to infect humans.

Learning Objectives:

-Make the connection between wildlife viruses and the emerging of new human viral diseases

-Discuss strategies to identify routes of contact and transmission of zoonotic viruses from animal to human

-Describe the technologies used in pathogen discovery.

-Review efforts to combat the emergence and re-emergence of high impact viral epidemics and pandemics compromising global health security and well-being of the peoples of the world.


Speaker: Jonna Mazet, PhD

Duration45 min

Recorded: November 2017

vaginal delivery
neonatal microbiota
Microbial Anthropology


In this presentation, the concept of microbial anthropology will be examined, exploring the human microbiome in peoples with different levels of integration to Western lifestyles in the Amazon region and Southern Africa. 

Learning Objectives:

-Explore the differences in microbiota of different groups of humans and the impact of Western lifestyles on the makeup of the human microbiome.

-Describe the impact of C-section versus vaginal delivery on skin microbiota composition during the first month of life.

-Entertain the possible connection betwee n human microbiota and environment and human diseases


Speaker: Maria Dominguez-Bello, PhD

Duration: 45 min

Recorded: November 2017

Emerging infectious diseases
zoonotic viruses
molecular identification
The Human Gastrointestinal Microbiome and Advances in Metagenomic Medicine


The Human gastrointestinal microbiome differentiates during infancy and childhood in terms of microbial composition and function. Microbial function is relatively conserved compared to microbial composition. Children have greater relative abundances of microbial genera such as Bifidobacterium and a greater genetic capacity to produce vitamins. The composition of the microbiome may affect relative susceptibilities to enteric infections, including recurrent C. difficile infection. Microbiome-based treatment modalities such as fecal microbiota transplantation may be necessary for successful treatment of disorders of microbial ecology. Differences in microbial composition and function may affect the course of functional bowel disorders such as irritable bowel syndrome. Finally the metabolic capacity of gut microbes may affect the pathology of inflammatory bowel disease via the production of anti-inflammatory metabolites. Diet, the microbiome and host genetics may have a profound impact on digestive disease phenotypes. Newer diagnostic approaches based on metagenomic medicine open new possibilities for diagnosis, stratification and treatment of patients with chronic gastrointestinal disorders.


Learning Objective:

-Describe key differences in the functional capacity of the pediatric versus adult gastrointestinal microbiomes.

-State the difference(s) in microbial composition among individuals who suffer from recurrent Clostridium difficile infection.

-Describe features in the microbiomes of individuals with irritable bowel syndrome, responding to dietary interventions.

-State basic mechanism(s) explaining how gut microbes reduce chronic intestinal inflammation.


Speaker: James Versalovich, MD, PhD 

Duration: 1hr 

Recorded: September 2017

fecal transplant
C. difficile
irritable bowel syndrome
recurrent abdominal pain
Closing Remarks, and Additional Materials
Individual topic purchase: Selected
Association for Molecular Pathology
AMP Certificate Program: 5.50
AMP Certificate ID
AMP Regular Member: $299.00
AMP Technologist Member: $299.00
AMP Associate Member: $299.00
Non-member Price: $399.00